Which statement best summarizes pregnancy management in diabetes?

Which statement best summarizes pregnancy management in diabetes?

• A. Perinatal risks increase with poor glycemic control, requiring more frequent insulin dose adjustments and close monitoring of maternal glucose and fetal well-being.
• B. Perinatal risks are not affected by maternal glycemic control, so insulin dosing should remain constant during pregnancy.
• C. Fetal monitoring is unnecessary if the mother's glucose is well controlled.
• D. After delivery, glucose targets should be increased beyond non-pregnant targets due to higher risk tolerance.

Answer: (A)

Maintaining tight glycemic control throughout pregnancy is essential because maternal glucose levels strongly influence fetal outcomes. Pregnancy brings hormonal changes that increase insulin resistance, especially in the second and third trimesters, so insulin needs often change week to week. When glycemic control is poor, the risk of adverse perinatal outcomes rises, including fetal overgrowth, birth complications, and neonatal hypoglycemia, among others. Therefore management focuses on adjusting insulin dosing as needed and closely monitoring both maternal glucose and fetal well-being to catch any problems early. That’s why the statement highlighting increased perinatal risks with poor glycemic control—and the need for more frequent insulin dose adjustments and careful monitoring of glucose and fetal status—best captures the approach to diabetes in pregnancy. In contrast, suggesting risks aren’t related to glycemic control, or that fetal monitoring isn’t needed if glucose is well controlled, or that targets should be increased after delivery, does not align with evidence-based practice. After delivery, insulin requirements drop rapidly and targets revert toward nonpregnant levels, rather than increasing.

Maintaining tight glycemic control throughout pregnancy is essential because maternal glucose levels strongly influence fetal outcomes. Pregnancy brings hormonal changes that increase insulin resistance, especially in the second and third trimesters, so insulin needs often change week to week. When glycemic control is poor, the risk of adverse perinatal outcomes rises, including fetal overgrowth, birth complications, and neonatal hypoglycemia, among others. Therefore management focuses on adjusting insulin dosing as needed and closely monitoring both maternal glucose and fetal well-being to catch any problems early.

That’s why the statement highlighting increased perinatal risks with poor glycemic control—and the need for more frequent insulin dose adjustments and careful monitoring of glucose and fetal status—best captures the approach to diabetes in pregnancy. In contrast, suggesting risks aren’t related to glycemic control, or that fetal monitoring isn’t needed if glucose is well controlled, or that targets should be increased after delivery, does not align with evidence-based practice. After delivery, insulin requirements drop rapidly and targets revert toward nonpregnant levels, rather than increasing.